Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:PG
Procter & Gamble
|
167.64 | -2,78% | 6,82% | 395.653,08 | 2,4% | 6,93% |
|
NYSE:ABT
Abbott Laboratories
|
104.09 | 2,43% | 15,17% | 181.078,48 | 2,1% | 9,04% |
|
NYSE:PFE
Pfizer
|
28.64 | 8,42% | 38,65% | 162.291,22 | 5,81% | -9,31% |
|
ENXTPA:SAN
Sanofi
|
89.17 | 19,33% | 38,3% | 111.472,92 | 4,17% | 8,19% |
|
LSE:GSK
GSK
|
17.75 | 7,44% | 23,26% | 72.385,16 | 3,25% | 0,79% |
|
NYSE:MCK
McKesson Corp
|
564.52 | -38,86% | -29,95% | 73.379,42 | 0,45% | 15,12% |
|
LSE:RKT
Reckitt Benckiser Group
|
45.93 | 41,37% | 58,37% | 32.339,7 | 4,17% | -1,02% |
|
XTRA:BAYN
Bayer
|
28.58 | 67,53% | 83,89% | 28.077,68 | 0,38% | 1,47% |
|
NYSE:CHD
Church & Dwight Co Inc
|
106.39 | -12,05% | -4,46% | 26.014,8 | 1,06% | 6,91% |
|
NYSE:PRGO
Perrigo Co PLC
|
29.83 | 35,17% | 58,31% | 4.186,4 | 3,67% | -10,73% |
|
OM:MOB
Moberg Pharma AB (publ)
|
24.70 | 0% | 0% | 1.079,87 | 0% | 0% |
